Mesna (Mesnex) Market, Global Outlook and Forecast 2024-2031

Report ID: 1372621 | Published Date: Jan 2025 | No. of Page: 73 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story

Coenzyme M (commonly known by it's salt form, Mesna) is a synthetic sulfhydryl (thiol) compound. Mesna, sold under the brand name Mesnex among others, is a medication used in those taking cyclophosphamide or ifosfamide to decrease the risk of bleeding from the bladder. It is used either by mouth or injection into a vein.
This report contains market size and forecasts of Mesna (Mesnex) in global, including the following market information:
Global Mesna (Mesnex) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mesna (Mesnex) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Mesna (Mesnex) companies in 2021 (%)
The global Mesna (Mesnex) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mesna (Mesnex) include Mylan, Baxter, Teva Pharmaceutical, Fresenius Kabi, Hikma Pharmaceuticals, Gland Pharma Limited, Sagent Pharmaceuticals, Athenex Pharmaceuticals and Jiangsu Hengrui Medicine. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mesna (Mesnex) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mesna (Mesnex) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Mesna (Mesnex) Market Segment Percentages, by Type, 2021 (%)
Oral
Injections
Global Mesna (Mesnex) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Mesna (Mesnex) Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Mesna (Mesnex) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Mesna (Mesnex) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mesna (Mesnex) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mesna (Mesnex) revenues share in global market, 2021 (%)
Key companies Mesna (Mesnex) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Mesna (Mesnex) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan
Baxter
Teva Pharmaceutical
Fresenius Kabi
Hikma Pharmaceuticals
Gland Pharma Limited
Sagent Pharmaceuticals
Athenex Pharmaceuticals
Jiangsu Hengrui Medicine

Frequently Asked Questions
Mesna Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Mesna Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Mesna Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Thymosin α1 Market

Thymosins can enhance body immunity and are mainly used in the treatment of hepatitis and tumors. ... Read More

Gonadorelin Market

Gonadorelin is a gonadotropin-releasing hormone agonist (GnRH agonist) which is used in fertility ... Read More

Terlipressin Market

Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypoten ... Read More